2) Verstraete, M. and Vermylen, J.: Antithrombotic and fibrinolytic agents and substances which lower blood viscosity. In. Thrombosis. Pergamon press, Oxford, England, 1984, p. 81.
3) Devies, G. C., Sobel, M. and Salzman, E. W.: Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation, 61: 808-814, 1980.
4) Stratta, P., Canavese, C., Mangiarotti, G., Pacitti, A., Tetta, C., Coppo. R,, Ragni, R. and Vercellone, A.: Heparin is unable to prevent activation by three different membranes. Proc Eur Dial Transplant Assoc. 18: 269-274, 1981.
5) Young, J. A., Kisker, C. T. and Doty, D. B.: Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of the fibrin monomer. Ann. Thorac. Surg., 26: 231-240, 1978.